1999
DOI: 10.1016/s0002-9394(98)00312-2
|View full text |Cite
|
Sign up to set email alerts
|

Anterior ischemic optic neuropathy following the use of a nasal decongestant

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
1
1

Year Published

2002
2002
2023
2023

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(10 citation statements)
references
References 2 publications
0
8
1
1
Order By: Relevance
“…A single case of visual impairment subsequent to the use of nasal decongestant was also excluded. 44 All articles that described cases in which facial injection had no pure cosmetic aim, such as sclerotherapy of vascular lesions [45][46][47][48][49][50][51] and corticosteroid injections for the treatment of chalazia, 52,53 were excluded.…”
mentioning
confidence: 99%
“…A single case of visual impairment subsequent to the use of nasal decongestant was also excluded. 44 All articles that described cases in which facial injection had no pure cosmetic aim, such as sclerotherapy of vascular lesions [45][46][47][48][49][50][51] and corticosteroid injections for the treatment of chalazia, 52,53 were excluded.…”
mentioning
confidence: 99%
“…Enhancement of the optic nerve in MRI is uncommon in both arteritic and nonarteritic AION, and subtle when present. 8,9 Enhancement of the optic nerve on MRI in the presence of optic disk swelling should raise the possibility of a process other than ischemia. A complete comparison of the characteristics of AION, malignant optic glioma, and optic neuritis is found in Table 1.…”
Section: Discussionmentioning
confidence: 99%
“…133 Medications Several medications have been implicated in the development of NAION, including sumatriptan, 134 sildenafil [phosphodiesterase type 5 (PDE-5) inhibitor], 135 amiodarone, 136 and nasal decongestants. 137 PDE-5 inhibitors have received significant recent attention for their possible relationship to NAION. Case reports have found visual loss occurring from 30 minutes to 36 hours after ingestion of the drug.…”
Section: Other Conditions Associated With Naionmentioning
confidence: 99%